Liver Center News

Understanding and categorizing the various types of tubulointerstitial responses in acute kidney injury (AKI) may lead to the development of new treatments for the condition, according to Yale School of Medicine researchers who published a review in The Journal of Clinical Investigation on March 17.

A Yale lab links skin inflammation to the development of food allergies via a skin-gut connection, suggesting clues to a little-understood immune reaction.

Yale School of Medicine’s Michael Schilsky, MD, professor of medicine (digestive diseases), discusses Wilson disease, a rare genetic disorder in which excessive copper accumulates in the body.

Joshua Warrick, MD, will join the Department of Pathology as a professor of pathology and senior research scientist on July 1, succeeding Peter Humphrey, MD, PhD, as director of genitourinary pathology.

Fat buildup in the liver can lead to severe damage and cancer. A new Yale study finds a therapeutic target for those at higher risk of fatty liver disease.

The Department of Internal Medicine announces its newest incoming class of residents for Match Day 2025.

Twelve Yale School of Medicine faculty members are among the leading experts in science, technology, engineering, mathematics, and medicine newly elected to the Connecticut Academy of Science and Engineering.

Meet Basile Njei, MD, MPH, PhD, assistant professor of medicine (digestive diseases). Njei is combining genetics and artificial intelligence (AI) to improve clinical outcomes, detect liver disease, and identify genetic and clinical predictors of liver disease. Njei is currently the co-director of the International Medicine Program in the Section of Digestive Diseases, through which he collaborates with the U.S. embassy in Cameroon to improve medical education and integrate AI into health care in Africa.

This year’s awardees are tackling some of the most urgent life science challenges with projects spanning novel therapeutics to AI-powered medical solutions.